Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Diagnostic Imaging

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 36 articles: HTML format

Single Articles

December 2025
1. KUO JH, Ou YC, Hu CY, Wu KY, et al
   Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures.
   Anticancer Res. 2025;45:5709-5720.
   PubMed     Abstract available
   
   
   
2. TAKENAKA S, Kimura M, Iwai M, Usami E, et al
   Determining Candidate D-dimer Thresholds for Lower-extremity Ultrasound in Monitoring Deep Vein Thrombosis in Patients With Gastric Cancer Receiving Ramucirumab.
   Anticancer Res. 2025;45:5735-5741.
   PubMed     Abstract available
   
   
   
3. NAYAB M, Elnaggar M, Asher V, Bali A, et al
   Comparative Analysis of FDG-PET Versus CT/MRI in Staging and Management of Advanced-stage Cervical Cancer.
   Anticancer Res. 2025;45:5503-5511.
   PubMed     Abstract available
   
   
   
4. ASANO Y, Sato T, Hozumi C, Han Q, et al
   FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient.
   Anticancer Res. 2025;45:5819-5824.
   PubMed     Abstract available
   
   
   November 2025
5. YOO SS, Banish K, Fahmi A, Glasener C, et al
   Focused Ultrasound-mediated Disruption of Plasma Protein Binding Enhances Chemotherapeutic Effects of Paclitaxel on Xenografted Ovarian Cancer in Mice.
   Anticancer Res. 2025;45:4697-4715.
   PubMed     Abstract available
   
   
   October 2025
6. HONG J, Fan R, Gao Y, Moes G, et al
   Sellar Metastatic Follicular Thyroid Carcinoma With Novel Mutations Clinically Mimicking Pituitary Macroadenoma: Intraoperative Frozen Section Diagnosis Challenges.
   Anticancer Res. 2025;45:4637-4641.
   PubMed     Abstract available
   
   
   September 2025
7. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
   Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
   Anticancer Res. 2025;45:3921-3930.
   PubMed     Abstract available
   
   
   
8. KATAYAMA R, Aoki T, Matsuda K, Yamazaki K, et al
   Assessment of Remnant Gastric Perfusion Using Indocyanine Green During Pancreaticoduodenectomy After Gastrectomy: A Case Report.
   Anticancer Res. 2025;45:4057-4062.
   PubMed     Abstract available
   
   
   June 2025
9. AIZAWA R, Ogata T, Goto T, Otani T, et al
   Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI.
   Anticancer Res. 2025;45:2515-2525.
   PubMed     Abstract available
   
   
   
10. MIZUTA K, Reynoso J, Asano Y, Kang BM, et al
    Tumor Immunology Visualized in Realtime in In-vivo-like 3-D Gelfoam((R)) Histoculture by Color-coded Imaging.
    Anticancer Res. 2025;45:2279-2283.
    PubMed     Abstract available
    
    
    May 2025
11. BOE N, Mautner VF, Friedrich RE, Farschtschi SC, et al
    Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2.
    Anticancer Res. 2025;45:2137-2146.
    PubMed     Abstract available
    
    
    April 2025
12. BLOMSTRAND H, Tesselaar E, Bjornsson B, Bartholoma W, et al
    PCD-CT Versus EID-CT in Imaging of Pancreatic Ductal Adenocarcinoma: A Prospective Comparative Pilot Study.
    Anticancer Res. 2025;45:1547-1558.
    PubMed     Abstract available
    
    
    March 2025
13. NEUGEBAUER J, Blum P, Keiler A, SUss M, et al
    Mismatch Between Preoperative MRI Findings and Postoperative Histological Results in the Treatment of Tenosynovial Giant Cell Tumor.
    Anticancer Res. 2025;45:1087-1096.
    PubMed     Abstract available
    
    
    
14. WHI W, Lee H, Hong JY, Kang W, et al
    (18)F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
    Anticancer Res. 2025;45:1273-1280.
    PubMed     Abstract available
    
    
    February 2025
15. OSHIRO A, Nagahashi M, Togashi Y, Kanaoka H, et al
    Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy.
    Anticancer Res. 2025;45:789-796.
    PubMed     Abstract available
    
    
    
16. SANTANA BN, Arencibia O, Babin G, Tommasetti E, et al
    Use of Indocyanine Green Fluorescence Angiography to Assess Bowel Anastomosis in Ovarian Cancer Surgery.
    Anticancer Res. 2025;45:661-666.
    PubMed     Abstract available
    
    
    January 2025
17. UCAR N, Deeney JT, Pickering RT, Fan TY, et al
    Interaction of Vitamin D-BODIPY With Fat Cells and the Link to Obesity-associated Vitamin D Deficiency.
    Anticancer Res. 2025;45:55-63.
    PubMed     Abstract available
    
    
    
18. PANOTOPOULOS C, Athanasiou G, Stavropoulos S, Boutos N, et al
    Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases.
    Anticancer Res. 2025;45:201-207.
    PubMed     Abstract available
    
    
    
19. KASUGA SO, Nozawa H, Ishihara S
    Changes in Mesorectal CT Values and Therapeutic Effect of Preoperative Chemoradiotherapy in Rectal Cancer.
    Anticancer Res. 2025;45:359-367.
    PubMed     Abstract available
    
    
    
20. OSHIRO H, Mizuta K, Miyashi Y, Yoshikawa Y, et al
    Relationship Between (18)F-FDG-PET/CT-derived Tumor Glucose Metabolic Activity, Nutritional Risk, and Survival in Patients With Soft-tissue Sarcoma.
    Anticancer Res. 2025;45:351-357.
    PubMed     Abstract available
    
    
    November 2024
21. LENZ C, Gesemann L, Al-Baldawi Y, Pusken M, et al
    Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer.
    Anticancer Res. 2024;44:5081-5085.
    PubMed     Abstract available
    
    
    
22. LEPPERT J, Ditz C, Matschke J, Matone MV, et al
    Preoperative Tumor Growth Rate Does Not Predict Overall or Progression-free Survival in Patients With Glioblastoma.
    Anticancer Res. 2024;44:5043-5049.
    PubMed     Abstract available
    
    
    October 2024
23. CHOI YJ, Ramos SC, Sim HB, Han JY, et al
    Promising Approach for Optimizing In Vivo Fluorescence Imaging in a Tumor Mouse Model: Precision in Cancer Research.
    Anticancer Res. 2024;44:4347-4358.
    PubMed     Abstract available
    
    
    September 2024
24. NAMIKAWA T, Yokota K, Munekage M, Maeda H, et al
    Robot-assisted Surgery for Gastrointestinal Cancer Using Indocyanine Green Conjugated Endoscopic Marking Clip Under Firefly Fluorescence Imaging.
    Anticancer Res. 2024;44:3937-3943.
    PubMed     Abstract available
    
    
    
25. SATO M, Sato T, Hozumi C, Han Q, et al
    [(11)C]Methionine PET vs. [(18)F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.
    Anticancer Res. 2024;44:3891-3898.
    PubMed     Abstract available
    
    
    August 2024
26. SHIMOMURA A, Oshima M, Suto H, Matsukawa H, et al
    Prognostic Significance of (18)F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma.
    Anticancer Res. 2024;44:3321-3330.
    PubMed     Abstract available
    
    
    July 2024
27. MIZUTA K, Gallagher S, Wang A, Chang N, et al
    Head-to-head Comparison of Green Fluorescent Protein (GFP) Imaging With Luciferase-luciferin Imaging In Vivo Using Single-nanometer Laser-excitation Tuning and an Ultra-low-light-detection Camera and Optics Demonstrates the Superiority of GFP.
    Anticancer Res. 2024;44:2823-2826.
    PubMed     Abstract available
    
    
    June 2024
28. LEONHARDI J, Horn LC, Aktas B, Denecke T, et al
    MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer - Associations With Histopathology.
    Anticancer Res. 2024;44:2709-2716.
    PubMed     Abstract available
    
    
    
29. OYA K, Tsuchie H, Nagasawa H, Hongo M, et al
    Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma.
    Anticancer Res. 2024;44:2487-2495.
    PubMed     Abstract available
    
    
    
30. PARK JS, Park HY, Choi Y
    Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer.
    Anticancer Res. 2024;44:2681-2687.
    PubMed     Abstract available
    
    
    May 2024
31. VANNI G, Materazzo M, Lorenzo ND, Tacconi F, et al
    Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride in Non-invasive Axillary Staging in Breast Cancer: Are we Missing a Chance?
    Anticancer Res. 2024;44:2021-2030.
    PubMed     Abstract available
    
    
    
32. TAMBURO M, Buffettino E, Pepe P, Marletta G, et al
    Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
    Anticancer Res. 2024;44:2205-2210.
    PubMed     Abstract available
    
    
    
33. PERRONE E, Taralli S, Pagliara D, Larocca LM, et al
    Breast Relapse of Pediatric B-Cell Acute Lymphoblastic Leukemia After CAR-T Therapy Detected by (18)F-FDG PET/CT.
    Anticancer Res. 2024;44:2243-2245.
    PubMed     Abstract available
    
    
    April 2024
34. TANAKA Y, Sato Y, Horaguchi T, Fujibayashi S, et al
    Radiomics Features Using Dual-energy CT for Lymph Nodes After Preoperative Chemotherapy for Esophageal Cancer.
    Anticancer Res. 2024;44:1661-1674.
    PubMed     Abstract available
    
    
    
35. AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al
    Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
    Anticancer Res. 2024;44:1583-1589.
    PubMed     Abstract available
    
    
    March 2024
36. KIKUCHI Y, Okuhashi Y, Ishihata H, Kashiba M, et al
    AI-based Apoptosis Cell Classification Using Phase-contrast Images of K562 Cells.
    Anticancer Res. 2024;44:935-939.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diagnostic Imaging is free of charge.